Current position:Home >Product >
Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(4-bromophenyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(4-bromophenyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-(503004-33-9)
- Name: Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(4-bromophenyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- Synonyms:
- Molecular Formula:C18H11BrN6S
- Molecular Weight:
- CAS Registry Number:503004-33-9
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 503004-00-0/3-Buten-1-one, 2,2-dimethyl-1,4-diphenyl-4-(phenylsulfonyl)-, (3Z)-
- 503004-01-1/Benzene, [2-methyl-1-[[(1Z)-2-phenyl-2-(phenylsulfonyl)ethenyl]oxy]-1-propenyl]-
- 503004-05-5/2-Oxazolidinone, 3-[(2S,3Z)-2-ethyl-1-oxo-4-phenyl-4-(phenylsulfonyl)-3-butenyl]-4-(phenyl methyl)-, (4S)-
- 503004-06-6/2-Oxazolidinone, 3-[(2R,3Z)-2-(1-methylethyl)-1-oxo-4-phenyl-4-(phenylsulfonyl)-3-butenyl ]-4-(phenylmethyl)-, (4S)-
- 503004-07-7/2-Oxazolidinone, 3-[(2S,3Z)-2-(1-methylethyl)-1-oxo-4-phenyl-4-(phenylsulfonyl)-3-butenyl] -4-(phenylmethyl)-, (4S)-
- 503004-08-8/2-Oxazolidinone, 3-[(2R,3Z)-1-oxo-4-phenyl-2-(phenylmethyl)-4-(phenylsulfonyl)-3-butenyl] -4-(phenylmethyl)-, (4S)-
- 503004-09-9/2-Oxazolidinone, 3-[(2S,3Z)-1-oxo-4-phenyl-2-(phenylmethyl)-4-(phenylsulfonyl)-3-butenyl] -4-(phenylmethyl)-, (4S)-
- 503004-22-6/Oxiranemethanamine, monolithium salt
- 503004-23-7/Oxiranemethanamine, monosodium salt
- 503004-26-0/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(1-methylethyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-27-1/Imidazo[2,1-b]-1,3,4-thiadiazole, 6-phenyl-2-propyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-28-2/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-hexyl-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-29-3/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-heptyl-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-30-6/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-octyl-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-31-7/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(2-chlorophenyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-32-8/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(4-chlorophenyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-33-9/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(4-bromophenyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-34-0/Imidazo[2,1-b]-1,3,4-thiadiazole, 2-(4-methylphenyl)-6-phenyl-5-(1H-1,2,4-triazol-1-yl)-
- 503004-77-1/2H-Pyran-2-one, 6-[(1E,3R)-3-[(4S,6R)-2,2-dimethyl-6-[(trimethylsilyl)ethynyl]-1,3-dioxan- 4-yl]-3-(methoxymethoxy)-1-butenyl]-5,6-dihydro-, (6R)-
- 503005-01-4/3-Pyrrolidinol, 4-ethenyl-1-[1-[(1S,2R,4R)-2-hydroxy-4-methylcyclohexyl]-1-methylethyl] -3-phenyl-, (3R,4S)-
- 503005-03-6/3-Pyrrolidinol, 4-(1-methylethenyl)-1-[(4-methylphenyl)sulfonyl]-3-phenyl-, (3R,4S)-
- 503004-76-0/2H-Pyran-2-one, 6-[(1E,3R)-3-[(4S,6S)-2,2-dimethyl-6-[(trimethylsilyl)ethynyl]-1,3-dioxan- 4-yl]-3-(methoxymethoxy)-1-butenyl]-5,6-dihydro-, (6R)-
- 503004-75-9/2H-Pyran-2-one, 6-[(1E,3R)-3-[(4R,6S)-2,2-dimethyl-6-[(trimethylsilyl)ethynyl]-1,3-dioxan- 4-yl]-3-(methoxymethoxy)-1-butenyl]-5,6-dihydro-, (6R)-
- 503004-74-8/2H-Pyran-2-one, 6-[(1E,3R)-3-[(4R,6R)-2,2-dimethyl-6-[(trimethylsilyl)ethynyl]-1,3-dioxan- 4-yl]-3-(methoxymethoxy)-1-butenyl]-5,6-dihydro-, (6R)-
- 503004-66-8/3-Pentenoic acid, 2-hydroxy-2-methyl-5-(phenylmethoxy)-, ethyl ester, (2R,3E)-
- 503004-54-4/4H-1-Benzopyran-4-one, 6-[[5,7-dimethoxy-2-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-8-yl]oxy ]-5,7-dimethoxy-2-(4-methoxyphenyl)-
- 503004-52-2/4H-1-Benzopyran-4-one, 6-[[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-8-yl]oxy]- 5,7-dihydroxy-2-(4-hydroxyphenyl)-
- 503004-46-4/2-Cyclohepten-1-one, 2-(hydroxyphenylmethyl)-
- 503004-44-2/3H-1,2,4-Triazole-3-thione, 4-amino-5-(2,4-dimethoxyphenyl)-2,4-dihydro-
- 503004-43-1/1,2,4-Triazolo[3,4-b][1,3,4]thiadiazole, 3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-6-(1H-1,2,4-triazol-1-ylmethyl )-